Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study
about
High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistanceThe role of antiplatelet therapy in the management of acute coronary syndromesAspirin and clopidogrel resistance: an emerging clinical entityClopidogrel resistance: myth or reality?Clopidogrel in the treatment of ischaemic heart diseasePlatelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO studyClopidogrel: an updated and comprehensive reviewAtorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.Effect of atorvastatin and clopidogrel co-administration after coronary stenting in korean patients with stable angina.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Modifiers of symptomatic embolic risk in infective endocarditis.Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation.Pharmacological basis of different targets for the treatment of atherosclerosis.Clopidogrel use in coronary artery disease.Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals.Clopidogrel resistance--the cardiologist's perspective.Potential roles for statins in critically ill patients.Spectrum of pleiotropic effects of statins in heart failure.Interaction between statins and clopidogrel: is there anything clinically relevant?Prasugrel: a critical comparison with clopidogrel.The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective.Antiplatelet therapy in acute coronary syndromes.Resistance to aspirin and clopidogrel therapy.Antiplatelet therapy and vascular disease: an update.The evolution of antiplatelet therapy in cardiovascular disease.Managing adverse effects and drug-drug interactions of antiplatelet agents.A comprehensive comparative review of adenosine diphosphate receptor antagonists.Proton pump inhibitors and clopidogrel: an association to avoid?Drug interactions with statins.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study.A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.Clopidogrel resistance: fact and fiction.Clopidogrel: cardiologists' panacea or neurologists' headache?Determinants to optimize response to clopidogrel in acute coronary syndromeUnderstanding clopidogrel efficacy in the presence of cytochrome P450 polymorphismIs clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?
P2860
Q26824850-4B69F30E-629E-4DBC-8C49-EE23AE77F1A7Q28176548-485B1F0E-D8E1-49B3-96EE-30293ADFD64EQ28194021-C9059341-B677-4247-86BE-B7AF8198C2F4Q28218055-09518BB5-9071-4F89-96FE-577E6E97576EQ28218576-32455CD9-9ABF-4542-8778-9622157583CDQ28218790-5394326C-CC77-4BF3-B1B8-76ECF49195BEQ28219411-A6C7230A-FCEA-4E79-9071-C2D82125BBA3Q33223756-0A564849-2A01-4B31-B624-896FF1D15C73Q34339780-DEE911E6-7107-4725-B149-0DB7F643ACDEQ34570910-2276E31D-DA12-4C49-93F3-3A570E09F800Q34580063-FBFC8720-1A89-494A-8D84-8FFB95011EDFQ34771381-C83B6770-A667-4246-A416-63164E3BCF7DQ35460905-D6047E81-A2C7-4806-84E8-4667924A745CQ36088008-86FC4906-5063-494A-B0A2-5F9DDA2186DBQ36346487-5CC29910-9E7D-4AC0-BD6E-D692CC883A2BQ36351993-BE57BA7F-DD4E-4BF6-A2E0-440A33C6CF7AQ36407222-A7BC28EF-635A-4A69-A41D-A76FA08B04FFQ36634214-DEFD8AC1-6361-470F-9A38-1A5B4D19A6D2Q36819608-B554E4A0-CD09-4912-B2BD-8E333A67D4DDQ36920701-1700DBAA-F1DA-4DEC-B103-ECA33D4DAA3AQ37146694-EBCFAD9D-71A9-4F95-9853-023AE42FEAB8Q37234094-ADE3753A-8CB1-47DF-9AB5-90667B8DCB96Q37641320-F663D6FB-DD10-4FF3-B941-AD92CA571C76Q37752429-283A57C6-3E20-4ECA-8959-CD18F30BCCBEQ37798110-AAB9622A-39EE-4F37-9C9E-669229A8ECEFQ37807524-C40AE3A9-4748-4EA4-9CDC-052DE12EAAEFQ37838100-4ED7C27F-67F8-4AC8-98BD-437A34D4B3C9Q37900470-8AAC5DB0-8AA0-4708-87E9-2CE32CC931C5Q37930967-71894A5A-3AF5-4E16-B6D8-4CEC779E0768Q37973114-52D9FCF8-7451-436A-A18E-17EFB792A09BQ38136990-5FBA7541-376D-4645-B3D5-96B57B314D95Q38155016-3409C1BF-73FC-434F-8FB4-1BAE913DEE79Q38307535-81DE4888-FE8B-48DE-8C84-D3855186160AQ38830803-CD54BCD3-AC23-45FF-9BEA-ED123F4D3FFAQ40329955-03748E3C-AFAD-4C30-967E-578F428C4B8AQ40347840-DA53B613-C462-4DD1-8A8B-1F9D8A1C5D74Q40393685-98BBF4EE-CD3F-4380-8C7D-BE49F33E7E38Q41848961-E98A4715-E6BF-4457-83B1-3BF0D4E742A7Q42425352-559698F4-3D98-4418-B98F-5CE921F2F80AQ42876416-87D52CFA-50DD-4EDA-BB9A-0AC79C843A51
P2860
Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Absence of interaction between ...... lts from the interaction study
@ast
Absence of interaction between ...... lts from the interaction study
@en
Absence of interaction between ...... lts from the interaction study
@nl
type
label
Absence of interaction between ...... lts from the interaction study
@ast
Absence of interaction between ...... lts from the interaction study
@en
Absence of interaction between ...... lts from the interaction study
@nl
prefLabel
Absence of interaction between ...... lts from the interaction study
@ast
Absence of interaction between ...... lts from the interaction study
@en
Absence of interaction between ...... lts from the interaction study
@nl
P2093
P1476
Absence of interaction between ...... lts from the interaction study
@en
P2093
Alex I Malinin
Benjamin R Oshrine
Charles H Hennekens
David C Sane
David R Lowry
Jean-François Tanguay
Mark G Midei
Peter B Berger
Victor L Serebruany
P304
P356
10.1001/ARCHINTE.164.18.2051
P407
P577
2004-10-11T00:00:00Z